| Beta‐blocker use and outcomes in patients with heart failure and mildly reduced and preserved ejection fraction S Matsumoto, AD Henderson, L Shen, T Kondo, M Yang, RT Campbell, ... European Journal of Heart Failure, 2024 | | 2024 |
| Race in Heart Failure: A Pooled Participant-Level Analysis of the Global PARADIGM-HF and PARAGON-HF Trials H Lu, BL Claggett, M Packer, MA Pabon, MA Pfeffer, EF Lewis, CSP Lam, ... JACC: Heart Failure, 2024 | | 2024 |
| Rates of Sudden Death After Myocardial Infarction—Insights From the VALIANT and PARADISE-MI Trials JP Curtain, MA Pfeffer, E Braunwald, BL Claggett, CB Granger, L Køber, ... JAMA cardiology, 2024 | | 2024 |
| Aptamer Proteomics for Biomarker Discovery in Heart Failure With Preserved Ejection Fraction: The PARAGON‐HF Proteomic Substudy NL Patel‐Murray, L Zhang, BL Claggett, D Xu, P Serrano‐Fernandez, ... Journal of the American Heart Association 13 (13), e033544, 2024 | | 2024 |
| A Genome-Wide Association Study of Oxypurinol Concentrations in Patients Treated with Allopurinol M Meloche, MO Pilon, S Provost, G Leclair, E Oussaïd, I St-Jean, M Jutras, ... Journal of Personalized Medicine 14 (6), 649, 2024 | | 2024 |
| Impact of left ventricular ejection fraction on cognitive function in chronic heart failure: insights from key-prognostic CPET parameters F Besnier, C Gagnon, B Berube, F Sellier, F Vachon, J Iglesies-Grau, ... European Journal of Preventive Cardiology 31 (Supplement_1), 2024 | | 2024 |
| Biological sex matters: cognitive performances and their predictors differ in female and male patients with heart failure C Gagnon, B Berube, F Besnier, F Vachon, F Sellier, J Iglesies-Grau, ... European Journal of Preventive Cardiology 31 (Supplement_1), 2024 | | 2024 |
| Physical functioning predicts cognition in systolic heart failure F Besnier, C Gagnon, F Sellier, B Berube, F Vachon, E Dupuy, ... European Journal of Preventive Cardiology 31 (Supplement_1), 2024 | | 2024 |
| Safety and Tolerability of Angiotensin Receptor-Neprilysin Inhibitor Initiation in High-Risk Acute Myocardial Infarction Relative to Care Setting: A Subgroup Analysis of the … CG De Pasquale, B Claggett, K Jering, JJV McMurray, D Mann, ZM Miao, ... Circulation: Heart Failure, e011393, 2024 | | 2024 |
| Effect of Sacubitril/Valsartan on Cognitive Function in Patients With Heart Failure With Preserved Ejection Fraction: A Prespecified Analysis of PARAGON-HF P Dewan, L Shen, J Pedro Ferreira, PS Jhund, IS Anand, A Chandra, ... Circulation, 2024 | | 2024 |
| Sacubitril/Valsartan in Patients With Heart Failure and Deterioration in eGFR to< 30 mL/min/1.73 m2 S Chatur, IE Beldhuis, BL Claggett, FR McCausland, BL Neuen, AS Desai, ... JACC: Heart Failure, 2024 | 1 | 2024 |
| Effects of sacubitril/valsartan across the spectrum of renal impairment in patients with heart failure S Chatur, BL Neuen, BL Claggett, IE Beldhuis, FR Mc Causland, ... Journal of the American College of Cardiology 83 (22), 2148-2159, 2024 | 1 | 2024 |
| Sacubitril/valsartan-related hypotension in patients with heart failure and preserved or mildly reduced ejection fraction A Foà, M Vaduganathan, BL Claggett, MA Pabon, H Lu, MA Pfeffer, ... Journal of the American College of Cardiology 83 (18), 1731-1739, 2024 | 4 | 2024 |
| High-sensitivity C-reactive protein in heart failure with preserved ejection fraction: Findings from TOPCAT JP Ferreira, BL Claggett, J Liu, A Sharma, AS Desai, IS Anand, E O'Meara, ... International Journal of Cardiology 402, 131818, 2024 | 5 | 2024 |
| Decreasing the Risk of Heart Failure in a Changing Post–Myocardial Infarction Environment J Rouleau New England Journal of Medicine 390 (16), 1524-1526, 2024 | 2 | 2024 |
| Angiotensin receptor-neprilysin inhibitor vs. placebo in congenital systemic right ventricular heart failure: the PARACYS-RV trial MA Chaix, A Dore, B Mondésert, FP Mongeon, V Roy, ... European Heart Journal 45 (16), 1481-1483, 2024 | 2 | 2024 |
| EFFECTS OF SACUBITRIL/VALSARTAN IN PATIENTS WITH HEART FAILURE ACROSS THE SPECTRUM OF KIDNEY RISK S Chatur, B Claggett, FM Causland, M Packer, AS Desai, JL Rouleau, ... Journal of the American College of Cardiology 83 (13_Supplement), 4605-4605, 2024 | | 2024 |
| SACUBITRIL/VALSARTAN, TREATMENT-RELATED HYPOTENSION, AND LEFT VENTRICULAR EJECTION FRACTION IN THE PARAGON-HF TRIAL A Foà, B Claggett, M Pabon, H Lu, MA Pfeffer, M Packer, O Vardeny, ... Journal of the American College of Cardiology 83 (13_Supplement), 376-376, 2024 | | 2024 |
| EFFECT OF SACUBITRIL/VALSARTAN ACCORDING TO POLYPHARMACY STATUS IN PARAGON-HF S Matsumoto, M Yang, L Shen, B Claggett, AS Desai, M Lefkowitz, ... Journal of the American College of Cardiology 83 (13_Supplement), 489-489, 2024 | 2 | 2024 |
| ABDOMINAL OBESITY AND OUTCOMES IN HEART FAILURE WITH PRESERVED EJECTION FRACTION: THE PARAGON-HF TRIAL A Peikert, M Vaduganathan, B Claggett, I Kulac, SE Litwin, MR Zile, ... Journal of the American College of Cardiology 83 (13_Supplement), 361-361, 2024 | | 2024 |
